Lindy Biosciences

About:

Lindy Biosciences is a development-stage protein therapeutic formulations company.

Website: https://www.lindybio.com/

Top Investors: Good Growth Capital, IAG Capital Partners, North Carolina Biotechnology Center, Next Act Fund, alumshares

Description:

Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​

Total Funding Amount:

$6.65M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)lindybio.com

Founders:

Deborah Bitterfield

Number of Employees:

1-10

Last Funding Date:

2022-03-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai